NSE · Healthcare · Drug Manufacturers - Specialty & Generic
EPS came in at -5.78 against a street estimate of 12.80 — a miss of 145.2%.
| Document | Date |
|---|---|
| Quarterly results · Q1 FY27 ALBERT DAVID LIMITED - Q1 FY2026-27 FINANCIAL SUMMARY HEADLINE NUMBERS • Revenue from operations (Q1 FY26-27): ₹10,133.55 crores — up 43.5% year-on- | 2026-08-06 |
| Quarterly results · Q4 FY26 KOTHARI ALBERT DAVID LIMITED – BOARD MEETING OUTCOME SUMMARY HEADLINE NUMBERS • Revenue from operations (FY 2025-26): Rs. 33,359.81 lacs • Profit be | 2026-05-14 |
| Quarterly results · Q3 FY26 ALBERT DAVID LIMITED - Q3 FY2025-26 SUMMARY HEADLINE NUMBERS • Q3 FY2025-26 Revenue from Operations: Rs 8,992.69 lakhs (vs Rs 8,308.29 lakhs in Q3 F | 2026-02-11 |
| Quarterly results · Q2 FY26 ALBERT DAVID LIMITED – FINANCIAL SUMMARY For Quarter & Half Year Ended 30 September 2025 --- HEADLINE NUMBERS • Q2 FY2026 Revenue from Operations: | 2025-11-12 |
| Quarterly results · Q1 FY26 ALBERT DAVID LIMITED – Q1 FY2025-26 FILING SUMMARY HEADLINE NUMBERS • Filing Date: August 2, 2025 • Quarter Covered: Q1 ended June 30, 2025 • Status | 2025-08-02 |
| Annual report FY2025 ALBERT DAVID LIMITED - ANNUAL REPORT FY 2024-25 SUMMARY HEADLINE NUMBERS • Revenue from Operations: ₹346 Crores for FY 2024-25 • Profit Before Tax: | 2025-07-04 |
| Quarterly results | 2025-02-12 |
| Quarterly results | 2024-11-14 |
Readable in the app.
| Action | Detail | Date |
|---|---|---|
| Dividend | ₹5 / share ex-date Jul 30, 2026 | 2026-07-30 |
Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for Albert David Limited — free to start.
Google PlayApp StoreData updated 2026-09-18.